Huntsman Cancer Institute (HCI) at the University of Utah (U of U) announced the appointment of Neeraj Agarwal, MD, physician-scientist at HCI and Professor of Internal Medicine at the U of U, as Senior Director of Clinical Research Innovation. In this role, Dr. Agarwal will oversee critical components of HCI’s clinical research infrastructure and lead efforts to bring innovative clinical trial offerings to patients. He will also serve as a leadership mentor to junior physician-scientists at HCI.
Neeraj Agarwal, MD
Neli Ulrich, PhD
“Dr. Agarwal is a highly accomplished, compassionate, and dedicated physician with a deep commitment to HCI’s mission, the patient experience, and innovation in research and clinical care,” said Neli Ulrich, PhD, Executive Director of the Comprehensive Cancer Center at HCI. “He is an internationally renowned leader in clinical research and a passionate advocate for cancer patients. He will be a valuable addition to our leadership team as we advance our vision for a cancer-free frontier.”
Dr. Agarwal has made long-standing contributions to clinical research in prostate, kidney, and bladder cancers. He is the overall study chair of multiple phase I/II and phase III trials and serves as a steering committee member of numerous other trials. His many accolades include a SWOG Young Investigator Award, the William D. Odell Young Investigator Award, and a National Cancer Institute Cancer Clinical Investigator Team Leadership Award. In 2018, he was appointed as HCI Presidential Endowed Chair in Cancer Research.
Dr. Agarwal serves as a panel member for the National Comprehensive Cancer Network guideline committees for bladder and kidney cancers. He is an advisor to the Oncology Drug Advisory Committee and the U.S. Food and Drug Administration, and he leads early therapeutics in the SWOG genitourinary cancers committee.
